Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

4.8K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.8K
Stem Cell Culture01:17

Stem Cell Culture

6.3K
Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...
6.3K
Embryonic Stem Cells00:57

Embryonic Stem Cells

5.5K
Embryonic stem (ES) cells were first discovered in mice in 1981 by Martin Evans. In 1998, James Thomson identified a method to isolate embryonic stem cells from humans. Human embryonic stem cells (hESCs) are obtained from 3-5 day old embryos that remain unused after an in vitro fertilization procedure.
ES cells are grown in a culture medium where they can divide indefinitely, creating ES cell lines. Under certain conditions, ES cells can differentiate, either spontaneously into a variety of...
5.5K
Tissue Transplantation01:24

Tissue Transplantation

1.1K
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
1.1K
Mesenchymal Stem Cells01:19

Mesenchymal Stem Cells

5.7K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
5.7K
Forced Transdifferentiation01:28

Forced Transdifferentiation

2.4K
Transdifferentiation, also known as lineage reprogramming, was first discovered by Selman and Kafatos in 1974 in silkmoths. They observed that the moths’ cuticle-producing cells transformed into salt-producing cells. Many such cases of natural transdifferentiation occur in organisms. In humans, pancreatic alpha cells can become beta cells. In newts, the loss of the eye’s lens causes the pigmented epithelial cells to transdifferentiate into the lens cells.
Artificial...
2.4K

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

A non-AI preliminary algorithm for the prediction and detection of highly pathogenic African swine fever in pigs using health monitoring collars.

Animal welfare (South Mimms, England)·2026
Same author

A two-tier framework for responsible research on human embryo models.

Cell·2026
Same author

Charting the translational pathway: ISSCR best practices for the development of PSC-derived therapies.

Stem cell reports·2026
Same author

CAR-NK Engineering to Overcome TME Barriers.

Cells·2026
Same author

Zeolitic Imidazolate Frameworks Allows for the Thermal Stabilization of Live Viral Vaccine in the Absence of Lyophilization.

ACS omega·2026
Same author

Systematic evaluation of CrRNA design parameters for optimized Cas13d-mediated RNA targeting in chicken cells.

Functional & integrative genomics·2025

関連する実験動画

Updated: Mar 1, 2026

Targeted and Selective Treatment of Pluripotent Stem Cell-derived Teratomas Using External Beam Radiation in a Small-animal Model
05:08

Targeted and Selective Treatment of Pluripotent Stem Cell-derived Teratomas Using External Beam Radiation in a Small-animal Model

Published on: February 17, 2019

6.7K

幹細胞ベースの治療に対する耐性戦略

Ann P Chidgey1, Daniel Layton, Alan Trounson

  • 1Monash Immunology and Stem Cell Laboratories, Building 75, STRIP, Monash University, Wellington Road, Clayton 3800, Victoria, Australia.

Nature
|May 16, 2008
PubMed
まとめ

組織再生のための胚性幹細胞治療は,免疫拒絶に直面します. 新しい戦略はこれを克服することを目的としていますが,これらの重要な細胞の長期的な移植を達成するには課題が残っています.

科学分野:

  • 再生医学は,再生医療である.
  • 免疫学 免疫学とは
  • 幹細胞生物学 幹細胞生物学

背景:

  • 胚性幹細胞 (ESC) は,組織と臓器の再生に有望である.
  • 成功するESCベースの治療には,移植された細胞の長期的な移植が必要です.
  • 免疫拒絶は,アロゲニック (非自己) 細胞移植の主要な障壁です.

研究 の 目的:

  • ESCベースの再生医療における免疫拒絶を克服するための課題と新興戦略をレビューする.
  • ESCsの臨床応用を可能にするために,成功する免疫耐性の必要性を強調する.

主な方法:

  • 細胞移植の免疫拒絶に関する現在の文献のレビュー.
  • 免疫耐性を誘発するための確立されたおよび新しいアプローチの分析.
  • これらのアプローチに関連する制限と課題の議論.

主要な成果:

  • 標準的な免疫抑制は,移植の拒絶を防ぐのに限られた成功を収めている.
  • 新興戦略には,耐性のための免疫再教育と,自律的な"自己"幹細胞の使用が含まれます.
  • 両方の新興戦略は,対処する必要があるユニークな課題を提示しています.

さらに関連する動画

In Vitro and In Vivo Assessment of T, B and Myeloid Cells Suppressive Activity and Humoral Responses from Transplant Recipients
18:48

In Vitro and In Vivo Assessment of T, B and Myeloid Cells Suppressive Activity and Humoral Responses from Transplant Recipients

Published on: August 12, 2017

15.0K
Development of Stem Cell-derived Antigen-specific Regulatory T Cells Against Autoimmunity
10:10

Development of Stem Cell-derived Antigen-specific Regulatory T Cells Against Autoimmunity

Published on: November 8, 2016

9.3K

関連する実験動画

Last Updated: Mar 1, 2026

Targeted and Selective Treatment of Pluripotent Stem Cell-derived Teratomas Using External Beam Radiation in a Small-animal Model
05:08

Targeted and Selective Treatment of Pluripotent Stem Cell-derived Teratomas Using External Beam Radiation in a Small-animal Model

Published on: February 17, 2019

6.7K
In Vitro and In Vivo Assessment of T, B and Myeloid Cells Suppressive Activity and Humoral Responses from Transplant Recipients
18:48

In Vitro and In Vivo Assessment of T, B and Myeloid Cells Suppressive Activity and Humoral Responses from Transplant Recipients

Published on: August 12, 2017

15.0K
Development of Stem Cell-derived Antigen-specific Regulatory T Cells Against Autoimmunity
10:10

Development of Stem Cell-derived Antigen-specific Regulatory T Cells Against Autoimmunity

Published on: November 8, 2016

9.3K

結論:

  • 免疫拒絶を克服することは,ESCベースの再生療法が臨床的に成功するために重要です.
  • 免疫耐性に対する新しいアプローチは開発中ですが,さらなる研究が必要です.
  • これらの免疫学的障壁に対処することは,再生医療の進歩に不可欠です.